Renaissance Technologies’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-722,390
Closed -$59K 4580
2022
Q4
$59K Sell
722,390
-634,556
-47% -$51.8K ﹤0.01% 3768
2022
Q3
$176K Sell
1,356,946
-279,289
-17% -$36.2K ﹤0.01% 3424
2022
Q2
$466K Buy
1,636,235
+1,464,317
+852% +$417K ﹤0.01% 3202
2022
Q1
$54K Sell
171,918
-34,117
-17% -$10.7K ﹤0.01% 3900
2021
Q4
$474K Buy
206,035
+91,837
+80% +$211K ﹤0.01% 3105
2021
Q3
$264K Buy
114,198
+16,147
+16% +$37.3K ﹤0.01% 3121
2021
Q2
$536K Sell
98,051
-32,500
-25% -$178K ﹤0.01% 2939
2021
Q1
$685K Sell
130,551
-35,100
-21% -$184K ﹤0.01% 2786
2020
Q4
$571K Sell
165,651
-41,100
-20% -$142K ﹤0.01% 2762
2020
Q3
$407K Sell
206,751
-66,500
-24% -$131K ﹤0.01% 2895
2020
Q2
$702K Sell
273,251
-16,100
-6% -$41.4K ﹤0.01% 2724
2020
Q1
$480K Sell
289,351
-21,165
-7% -$35.1K ﹤0.01% 2777
2019
Q4
$187K Buy
310,516
+3,500
+1% +$2.11K ﹤0.01% 3214
2019
Q3
$310K Buy
307,016
+3,700
+1% +$3.74K ﹤0.01% 3026
2019
Q2
$440K Buy
303,316
+9,900
+3% +$14.4K ﹤0.01% 3044
2019
Q1
$493K Buy
293,416
+6,100
+2% +$10.2K ﹤0.01% 2923
2018
Q4
$290K Buy
287,316
+5,400
+2% +$5.45K ﹤0.01% 3033
2018
Q3
$567K Buy
281,916
+12,800
+5% +$25.7K ﹤0.01% 2814
2018
Q2
$662K Buy
269,116
+9,500
+4% +$23.4K ﹤0.01% 2749
2018
Q1
$797K Buy
259,616
+18,600
+8% +$57.1K ﹤0.01% 2743
2017
Q4
$966K Buy
241,016
+24,000
+11% +$96.2K ﹤0.01% 2670
2017
Q3
$747K Buy
217,016
+24,300
+13% +$83.6K ﹤0.01% 2677
2017
Q2
$569K Buy
192,716
+157,700
+450% +$466K ﹤0.01% 2727
2017
Q1
$56K Buy
35,016
+23,100
+194% +$36.9K ﹤0.01% 3132
2016
Q4
$17K Buy
+11,916
New +$17K ﹤0.01% 3207
2015
Q3
Sell
-16,266
Closed -$71K 3426
2015
Q2
$71K Sell
16,266
-31,987
-66% -$140K ﹤0.01% 3127
2015
Q1
$172K Buy
+48,253
New +$172K ﹤0.01% 2919
2014
Q3
Sell
-1,910
Closed -$18K 3003
2014
Q2
$18K Sell
1,910
-524
-22% -$4.94K ﹤0.01% 2744
2014
Q1
$33K Sell
2,434
-1,981
-45% -$26.9K ﹤0.01% 2773
2013
Q4
$103K Buy
+4,415
New +$103K ﹤0.01% 2720